Miss Kate Davies

(she/her)

MA, MPhil, AFHEA

2025

• Davies, K. et al. 2025. NKG2A-mediated immune modulation of natural killer cells by Staphylococcus aureus. The Journal of Immunology vkaf174. (10.1093/jimmun/vkaf174)
• Luu Hoang, K. N. et al., 2025. BTN2A1 and BTN3A1 as novel coeliac disease risk loci: an in silico analysis. International Journal of Molecular Sciences 26 (21) 10697. (10.3390/ijms262110697)
• McFadzean, I. J. et al. 2025. The evolution of patient-reported safety concerns during the COVID-19 pandemic within a series of study questionnaires: a multi-method analysis. International Journal for Quality in Health Care 37 (2) mzaf040. (10.1093/intqhc/mzaf040)

2023

• Keers, R. N. et al., 2023. Defining avoidable healthcare-associated harm in prisons: a mixed-method development study. PLoS ONE 18 (3) e0282021. (10.1371/journal.pone.0282021)
• McFadzean, I. J. et al. 2023. Patient safety in prisons: a multi-method analysis of reported incidents in England. Journal of the Royal Society of Medicine 116 (7), pp.236-245. (10.1177/01410768231166138)
• Shepherd, F. R. et al. 2023. The superantigens SpeC and TSST-1 specifically activate TRBV12-3/12-4+ memory T cells. Communications Biology 6 78. (10.1038/s42003-023-04420-1)
• Siggins, M. K. et al., 2023. Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.. Immunology 168 (3), pp.473-492. (10.1111/imm.13585)
• Veteleanu, A. et al. 2023. Complement dysregulation and Alzheimer's disease in Down syndrome. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 19 (4), pp.1383-1392. (10.1002/alz.12799)

2021

• Syrimi, E. et al., 2021. The immune landscape of SARS-CoV-2-associated multisystem inflammatory syndrome in children (MIS-C) from acute disease to recovery. iScience 24 (11) 103215. (10.1016/j.isci.2021.103215)